Intervention not reported
Major adverse cardiovascular events (MACE) · people with cardiovascular disease or at high risk of cardiovascular disease
The intervention probably leads to lower major adverse cardiovascular events (MACE) (moderate certainty).
1 finding from 1 review
- Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events 2018 · Cochrane Headline outcomes onlyRR 0.94 [0.9, 0.98]10 studies · 21727 participantsModerate